Immunocore Holdings plc (IMCR:NASDAQ) closed at $32.62 on October 22, 2026, up 1.65% on the day. The stock trades 19.9% below its 52-week high of $40.72 and 18.6% above its 52-week low of $27.50. Over the past year, it lost 1.3%. Immunocore Holdings plc is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, IMCR closed higher on 122 days (48%). Its best day was October 20, 2026 (+9.25%) and its worst was April 21, 2026 (-6.17%). It never moved 10% or more in a single session.
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
Find more stocks like IMCR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.